Anavex Life Sciences Corp (AVXL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Summary

Anavex Life Sciences Corp (Anavex) is a clinical-stage biopharmaceutical company that focuses on developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, other central nervous system (CNS) diseases, pain and various types of cancer. The companys target indications include Alzheimers disease, Parkinsons disease, Rett syndrome, epilepsy, neuropathic pain, depression, prostate cancer, pancreatic cancer and malignant melanoma. Its pipeline comprises one drug candidate and several compounds in diverse stages of pre-clinical study. Anavexs lead compound ANAVEX 2-73 is being developed for the treatment of Alzheimers disease, Parkinsons disease and potentially other CNS diseases, including rare diseases. Anavex is headquartered in New York, the US.

Anavex Life Sciences Corp (AVXL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

2
List of Tables 4
List of Figures 5
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Anavex Life Sciences Corp, Medical Devices Deals, 2011 to YTD 2017 10
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Anavex Life Sciences Enters into Partnership with Ariana Pharmaceuticals 12
Anavex Enters Into Agreement With Roskamp Institute To Develop ANAVEX PLUS 12
Licensing Agreements 13
Anavex Enters Into Licensing Agreement With Life Science Research Israel 13
Equity Offering 14
Anavex Life Sciences Files Registration Statement for Public Offering of Shares for up to USD29 Million 14
Anavex Life Sciences Files Registration Statement for Public Offering of Shares for up to USD100 Million 15
Anavex Life Sciences to Raise USD0.5 Million in Private Placement of Shares and Warrants 16
Anavex Life Sciences Announces Private Placement Of Units For US$2.6 Million 18
Anavex Life Sciences Completes First Tranche Of Private Placement Of Shares For US$0.1 Million 19
Anavex Life Sciences Raises US$1.6 Million Upon Exercise Of Warrants 20
Debt Offering 21
Anavex Life Sciences Completes Private Placement Of Debenture For US$10 Million 21
Anavex Life Sciences Corp - Key Competitors 23
Key Employees 24
Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Financial Announcements 26
May 10, 2017: Anavex Reports Fiscal Second Quarter 2017 Financial Results 26
Feb 07, 2017: Anavex Reports Fiscal First Quarter 2017 Financial Results 27
Aug 11, 2016: Anavex Reports Fiscal Third Quarter 2016 Financial Results 28
May 11, 2016: Anavex Reports Fiscal Second Quarter 2016 Financial Results 29
Feb 08, 2016: Anavex Reports Fiscal First Quarter 2016 Financial Results 30
Corporate Communications 31
May 01, 2017: Anavex Life Sciences Appoints Former FDA Officer as Senior Vice President of Regulatory Affairs 31
Feb 13, 2017: Anavex Life Sciences Strengthens Board of Directors 32
Legal and Regulatory 33
Mar 30, 2017: Anavex Life Sciences Reports Dismissal of Appeal in the Cortina Lawsuit 33
Jan 03, 2017: Anavex Life Sciences Obtains Permanent Dismissal of All Claims in Securities Lawsuit 34
Clinical Trials 35
Mar 10, 2016: Anavex Announces Two-Year Clinical Extension Study of ANAVEX 2-73 and Presents Phase 2a Dose-Response Analysis at AAT Conference 35
Feb 25, 2016: Anavex Presents Preclinical Results of ANAVEX 2-73 in Rett Syndrome 36
Feb 17, 2016: ANAVEX 2-73 Preclinical Data in New Indication to be Presented at ACTRIMS 2016 37
Jan 11, 2016: Anavex Announces Positive Dose-Response Data for ANAVEX 2-73 in Alzheimer Disease Patients 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List Of Tables


Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Anavex Life Sciences Corp, Deals By Therapy Area, 2011 to YTD 2017 9
Anavex Life Sciences Corp, Medical Devices Deals, 2011 to YTD 2017 10
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Anavex Life Sciences Enters into Partnership with Ariana Pharmaceuticals 12
Anavex Enters Into Agreement With Roskamp Institute To Develop ANAVEX PLUS 12
Anavex Enters Into Licensing Agreement With Life Science Research Israel 13
Anavex Life Sciences Files Registration Statement for Public Offering of Shares for up to USD29 Million 14
Anavex Life Sciences Files Registration Statement for Public Offering of Shares for up to USD100 Million 15
Anavex Life Sciences to Raise USD0.5 Million in Private Placement of Shares and Warrants 16
Anavex Life Sciences Announces Private Placement Of Units For US$2.6 Million 18
Anavex Life Sciences Completes First Tranche Of Private Placement Of Shares For US$0.1 Million 19
Anavex Life Sciences Raises US$1.6 Million Upon Exercise Of Warrants 20
Anavex Life Sciences Completes Private Placement Of Debenture For US$10 Million 21
Anavex Life Sciences Corp, Key Competitors 23
Anavex Life Sciences Corp, Key Employees 24

List Of Figures


Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Anavex Life Sciences Corp, Medical Devices Deals, 2011 to YTD 2017 10

Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review

Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

USD 125 View Report

Global Life Sciences & Analytical Reagents Market Research Report 2023-2027

In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Life Sciences & Analytical Reagents Report by Material, Application, and Geography

USD 3200 View Report

Global Protective Clothing for Life Sciences Market 2022 - Industry Briefing

According to market research study published by , the global protective clothing for life sciences market is expected to reach approximately USD 5,361 million, representing a CAGR of 5.6% during

USD 800 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available